TG Therapeutics Conference Call Announcement for 2025

Author: Ryan Hughes Updated: 02-26-2025 08:00 AM

Conference Call Details for TG Therapeutics

TG Therapeutics, Inc. (NASDAQ: TGTX) has scheduled a significant conference call on March 3, 2025, at 8:30 AM ET specifically aimed at discussing their financial performance for the fourth quarter and the entirety of 2024. Michael S. Weiss, the Chair and CEO, will lead the discussion.

How to Join the Conference Call

For those interested in joining the call, participants can dial in using the following numbers: 1-877-407-8029 (within the U.S.) or 1-201-689-8029 (for international callers). The conference is titled "TG Therapeutics Earnings Call." Additionally, a live audio webcast will be accessible through the Events page on the company's website.

After the Call – What to Expect

Following the call, attendees will have the opportunity to listen to a recording that will be available for 30 days after the event. This will allow investors and stakeholders to revisit the conference highlights and financial insights shared.

About TG Therapeutics

TG Therapeutics stands firm as a fully integrated biopharmaceutical company dedicated to creating and commercializing innovative therapies for B-cell diseases. The company is known for its robust pipeline of investigational drugs and has successfully gained FDA approval for its product, BRIUMVI (ublituximab-xiiy), aimed at treating adult patients dealing with relapsing forms of multiple sclerosis. This approval is also in line with the European Commission's endorsement and the U.K.'s Medicines and Healthcare Products Regulatory Agency, reinforcing their commitment to delivering novel treatments.

Future Prospects and Innovations

As 2025 approaches, TG Therapeutics is not just reflecting on past achievements but also setting the stage for future endeavors. With ongoing research and development efforts, they aim to expand their portfolio further, focusing on unmet medical needs within the realm of B-cell diseases.

Investment and Growth Strategies

The company's growth strategy is centered around both expanding its existing treatments and exploring new avenues for research. Collaborations with leading healthcare institutions and investment in clinical trials are key components of their plan.

Community and Customer Engagement

Moreover, TG Therapeutics is committed to engaging with the community and stakeholders, emphasizing transparency and communication as vital elements of their operational philosophy. Regular updates on their progress aim to foster trust and reliability among investors and patients alike.

Frequently Asked Questions

What is the purpose of the conference call on March 3, 2025?

The conference call aims to discuss TG Therapeutics' fourth-quarter and full-year financial results for 2024 and outline business expectations for 2025.

Who can participate in the conference call?

Anyone interested in the call can participate by using the specified dial-in numbers provided for U.S. and international callers.

How can I access the recording of the call?

The audio recording will be made available on TG Therapeutics' website for 30 days following the live event.

What medications does TG Therapeutics focus on?

TG Therapeutics specializes in developing treatments for B-cell diseases, particularly noted for its FDA-approved drug BRIUMVI for multiple sclerosis.

How does TG Therapeutics engage with stakeholders?

The company prioritizes transparency and communication with stakeholders through regular updates on research progress and financial outcomes.

About The Author

Hello, my name is Ryan Hughes. I am a financial, economics, and stock market specialist committed to assisting people in negotiating the intricacies of the financial system. Having a great deal of experience and a thorough grasp of market dynamics and economic trends, my area of expertise is converting complex financial ideas into understandable, practical knowledge. By use of my articles and blog entries, I hope to give you the information and assurance you need to make wise financial choices.

I've had the honor of interacting with a wide range of readers as a writer for several financial blogs, from new investors to seasoned market participants. To enable you to reach your financial goals, I want to make finance, economics, and stock market trends understandable and approachable. I appreciate you traveling with me toward success and financial literacy.

Contact Ryan Hughes privately here. Or send an email with ATTN: Ryan Hughes as the subject to contact@investorshangout.com.

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.